Highlights the role of growth factors and the renin-angiotensin system in vascular remodeling in hypertension, and the differential effects of antihypertensive classes on reversing these structural changes.
No takes yet. Share an insight, caveat, or question.
Supports ACE inhibitor preference for reversing resistance artery remodeling in hypertension; leaves open impact on clinical outcomes.
Lee et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: